Stage IV non-small cell lung cancer
Approximately 60% of non-small cell lung cancers (NSCLC) are metastatic at diagnosis.1 The diagnosis of metastatic (stage IV) lung cancer has long been associated with a dismal prognosis, and median survival times of less than one year, however the era of personalised medicine and immunotherapy is bringing about...
Read more